Q3 2025 CV Sciences Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT
Release Date Price: $0.05

Key Points

Positve
  • CV Sciences Inc (CVSI) reported a strong gross margin of 48.5% for Q3 2025, indicating efficient cost management.
  • The company maintained its number one position in the natural product retail channel and increased its market share.
  • CV Sciences Inc (CVSI) is adapting its product innovation efforts to include more non-cannabinoid products, diversifying its offerings.
  • The acquisition of Elevated Soft Gels is expected to improve cost efficiency and gross margin through insourcing manufacturing.
  • New product innovation is a key driver, with products launched since early 2023 representing 39% of total revenue in Q3 2025.
Negative
  • Revenue for Q3 2025 was $3.3 million, down 10% sequentially and 16% year-over-year, primarily due to temporary out-of-stock issues and restrictive regulations.
  • The company faces significant regulatory challenges, with new federal legislation potentially impacting the sale of hemp products.
  • Adjusted EBITDA showed a loss of $118,000, indicating ongoing financial challenges.
  • Direct-to-consumer revenue was down about 2% sequentially, reflecting lower site traffic.
  • The company reported a net loss of $0.4 million for Q3 2025, slightly higher than the previous quarter.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CVSI.PK - CV Sciences Inc
Q3 2025 CV Sciences Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to the CV Science's 3rd quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. A brief question-and-answer session from the analyst community will follow the formal presentation. If anyone should require operator assistance during the conference, please press 0 on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Brendan Hawkins, Investor relations.

Thank you, sir. You may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and good
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot